Follow-up to: Is IL-6 from infections enough to cause AF in people?
Question explored with the scientific record
How does the pneumococcal vaccine interact with NLRP3
The short version: the pneumococcal vaccine strongly activates NLRP3 and boosts IL-1β and IL-6, but no study has directly tested whether this triggers atrial fibrillation.
The 2013 PBMC study shows PCV7 alone drives IL-1β to 178.5 pg/mL and IL-6 to 1,872 pg/mL in human immune cells [1]. Combined with DPT and Hib, the cytokine storm multiplies: IL-1β hits 510.9 pg/mL and IL-6 reaches 4,033 pg/mL [1]. Both cytokines are established drivers of NLRP3-mediated atrial fibrosis and AF susceptibility [2, 3].
| Stimulation | IL-1β (pg/mL) | IL-6 (pg/mL) |
|---|---|---|
| Control | not reported | 4.56 |
| PCV7 alone | 178.5 | 1,872 |
| DPT/Hib/PCV7 | 510.9 | 4,033 |
| Influenza (admitted) | 19.44 | 35.93 |
PCV7 generates 9 times more IL-1β than a serious influenza infection [1]. That is a massive inflammatory signal delivered to the heart, exactly the kind of NLRP3 activation that the cardiology reviews link to AF initiation and maintenance [2, 3]. But no study in the retrieved evidence measured whether PCV7 actually causes AF in adults or children. The gap is the link.
My call: the mechanism is plausible and the cytokine data is concerning, but the evidence connects PCV7 to NLRP3 activation, not directly to atrial fibrillation. Confidence: low that current evidence answers the question.
Sources examined 3
-
Production of inflammatory cytokines in response to diphtheria-pertussis-tetanus (DPT), haemophilus influenzae type b (Hib), and 7-valent pneumococcal (PCV7) vaccines
This study investigates how combinations of DPT, Hib, and PCV7 vaccines stimulate inflammatory cytokines in vitro in human PBMCs and examines serum cytokine profiles in vaccine recipients, identifying distinct innate immune signatures associated with multi-vaccine reactogenicity…
DOI: 10.4161/hv.27264 -
Implications of Inflammation and Fibrosis in Atrial Fibrillation Pathophysiology
A narrative review detailing how inflammation and fibrosis drive atrial fibrillation (AF) pathophysiology, including the roles of the inflammasome, fibroblast activation, epicardial adipose tissue, biomarkers/imaging, and potential upstream/immunomodulatory therapies to mitigate…
DOI: 10.1016/j.ccep.2020.11.002 -
Inflammasome Signaling in Cardiac Arrhythmias: Linking Inflammation, Fibrosis, and Electrical Remodeling
A comprehensive state-of-the-art review synthesizing mechanistic and translational evidence that NLRP3 inflammasome signaling links inflammation, fibrosis, and electrical remodeling to atrial and ventricular arrhythmias, highlighting upstream triggers (metabolic stress, obesity,…
DOI: 10.3390/ijms26135954